## Abstract ## Objective It is hypothesized that the systemic inflammation associated with rheumatoid arthritis (RA) promotes an increased risk of cardiovascular (CV) morbidity and mortality. We examined the risk and determinants of congestive heart failure (CHF) in patients with RA. ## Methods
High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: A population-based cohort study
✍ Scribed by Hilal Maradit Kremers; Cynthia S. Crowson; Terry M. Therneau; Veronique L. Roger; Sherine E. Gabriel
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 109 KB
- Volume
- 58
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Objective
To estimate the 10‐year absolute risk of cardiovascular (CV) events in newly diagnosed rheumatoid arthritis (RA) patients and the potential contribution of CV risk factors to absolute risk assessment.
Methods
A population‐based incidence cohort of RA patients (defined according to the American College of Rheumatology 1987 criteria) was assembled and compared with an age‐ and sex‐matched non‐RA cohort. Data were collected on CV risk factors and CV events. Cox regression models were used to estimate the 10‐year risk of a combined CV end point, adjusting for CV risk factors. Subjects were classified into 5 risk categories based on their 10‐year absolute risk.
Results
The absolute CV risk in RA patients was similar to that in non‐RA subjects who were 5–10 years older. The absolute risk varied substantially according to the presence of CV risk factors. The 10‐year absolute CV risk among 60–69‐year‐old RA patients with no risk factors was 16.8%, but rose to 60.4% if risk factors such as smoking, hypertension, dyslipidemia, diabetes, and obesity were present. Among RA patients with a low body mass index, in addition to the above risk factors, the 10‐year absolute CV risk rose to 86.2%.
Conclusion
More than half of the newly diagnosed RA patients who were 50–59 years of age and all of those >60 years of age had a >10% risk of CV disease within 10 years of their RA incidence and should be targeted for specific CV risk reduction strategies tailored to their personal risk profiles.
📜 SIMILAR VOLUMES
## Abstract ## Objective Limited data have been published on tolerance to and efficacy of classic or biologic disease‐modifying antirheumatic drugs in elderly patients with rheumatoid arthritis (RA). The goal of the present study was to evaluate the tolerance to and effectiveness of anti–tumor nec
## Abstract ## Objective In early rheumatoid arthritis (RA), longitudinal studies have demonstrated that magnetic resonance imaging (MRI) is more sensitive than radiography in demonstrating progressive erosive joint damage. The present study evaluated the progression of erosive damage in patients